Trial of Center-Based Early Start Denver Model vs. Pivotal Response Treatment in Children With Autism (NCT07522190)
Randomized Controlled Trial of Center-Based Early Start Denver Model (ESDM) vs. Pivotal Response Treatment (PRT) in Children With Autism
🩺 Plain-English Summary (8th-Grade Level)
The goal of this study is to compare two well-established early autism interventions, Early Start Denver Model (ESDM) and Pivotal Response Treatment (PRT), to better understand which approach is most effective for improving communication skills in young children with autism and which children may benefit most from each treatment. Additionally, after completing either the ESDM or PRT, some participants who meet specific clinical criteria may be offered home-based Developmental Reciprocity Treatment (DRT). The study will include boys and girls 2 to 4 years 11 months old diagnosed with ASD. The main questions this study aims to answer are whether center-based ESDM and center-based PRT improve communication skills in young children with autism, and whether certain children respond better to one treatment approach than the other. Participants will be randomly assigned to either ESDM or PRT for 24 weeks in a center-based program, attend treatment session 4 days per week (\~3 hours/day), complete developmental and autism assessments at baseline, 12 weeks, and 24 weeks, have a parent participate in weekly parent training sessions, and complete follow-up assessments at weeks 36 and 48.
Who can join: Review the eligibility criteria below.
Location: Stanford University — Palo Alto, California
Age range: 2 Years to 4 Years
🧪 Interventions in This Study
- Early Start Denver Model (ESDM) (BEHAVIORAL)
- Pivotal Response Treatment (PRT) (BEHAVIORAL)
- Developmental Reciprocity Treatment (DRT) (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Stanford University — Palo Alto, California
📞 Contact the Study Coordinator
Phone: (650) 736-1235
Email: PALprogram@stanford.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Autism Spectrum Disorder (ASD)
- Mental And Speech Developmental Delay Autism Spectrum-Type Behavioral Disorder — New York, New York
- Diné Parents Taking Action Trial — Flagstaff, Arizona
- Navigating the Transition to Adulthood: A Dual Language Mobile App for Latino Youth With ASD and Their Families — Houston, Texas
- Promoting Physical Activity Among Young Children With Autism — Boston, Massachusetts
- A Cognitive Behavioral Therapy Approach to Addressing Anxiety in Children With ASD and Intellectual Disability — London, Ontario
Explore by condition: All Autism Spectrum Disorder (ASD) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.